BIOMAT Database Logo BIOMAT Database Logo

Tumor cell differentiation modulates susceptibility to natural killer cells. 1982

J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.
December 2015, Oncoimmunology,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.
July 2012, The Journal of clinical investigation,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Natural killer cells and their targets: impact of differentiation on target cell susceptibility.
January 1983, Haematology and blood transfusion,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
May 1983, Immunobiology,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Tumor cell recognition by natural killer cells.
February 2002, Seminars in cancer biology,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Polyglutamine protein in tumor cells sensitizes tumor cells to natural killer cell cytolysis.
August 2020, Molecular immunology,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Natural killer cell immunotherapy to target stem-like tumor cells.
January 2016, Journal for immunotherapy of cancer,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Genetic susceptibility to natural killer T-cell lymphoma.
February 2020, The Lancet. Oncology,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Modulation of target cell susceptibility to human natural killer cells by interferon.
May 1980, International journal of cancer,
J Werkmeister, and S L Helfand, and T Haliotis, and P Rubin, and H Pross, and J Roder
Resveratrol diminishes platelet aggregation and increases susceptibility of K562 tumor cells to natural killer cells.
February 2013, Indian journal of biochemistry & biophysics,
Copied contents to your clipboard!